Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs United Airlines Holdings Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while United Airlines Holdings Inc trades at $99.02 (market cap $32.12B). The key difference: United Airlines Holdings Inc is far larger — about 3.6× Kymera Therapeutics Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and United Airlines Holdings Inc for 46 Days on average.
| KYMR | UAL | |
|---|---|---|
Market Cap | $8.88B | $32.12B |
Volume | 1,028,790 | 5,419,148 |
Sector | Health | Industrials |
52-Week High | $127.31 | $136.11 |
52-Week Low | $55.80 | $85.21 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $8.27B | $49.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
United Airlines (UAL) trades at $103.21, down 1.18% today, with strong fundamentals including a low P/E of 9.27 and consistent earnings beats. The company shows robust revenue growth from $45B in 2022 to $59.1B in 2025, with net income rising to $3.35B. Technical indicators are bearish with support at $101, while analyst consensus remains strongly bullish with a $158.10 price target. Recent news highlights aggressive customer acquisition strategies targeting Delta and American's premium flyers.
UAL presents a compelling value opportunity with attractive valuation metrics and strong profitability, though near-term technical weakness and rising fuel costs pose risks. The company's strategic moves to capture premium customers and Starlink partnerships provide growth catalysts, while analyst optimism suggests significant upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
